Unknown

Dataset Information

Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model.


ABSTRACT: The universal modular chimeric antigen receptor (UniCAR) platform redirects CAR-T cells using a separated, soluble targeting module with a short half-life. This segregation allows precise controllability and flexibility. Herein we show that the UniCAR platform can be used to efficiently target solid cancers in vitro and in vivo using a pre-clinical prostate cancer model which overexpresses prostate stem cell antigen (PSCA). Short-term administration of the targeting module to tumor bearing immunocompromised mice engrafted with human UniCAR-T cells significantly delayed tumor growth and prolonged survival of recipient mice both in a low and high tumor burden model. In addition, we analyzed phenotypic and functional changes of cancer cells and UniCAR-T cells in association with

SUBMITTER: Pishali Bejestani E 

PROVIDER: S-EPMC5665068 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature